急性冠状动脉综合征患者危险因素的性别差异

路英进, 曲艳武, 侯亮, 等. 急性冠状动脉综合征患者危险因素的性别差异[J]. 临床心血管病杂志, 2015, 31(8): 835-840. doi: 10.13201/j.issn.1001-1439.2015.08.010
引用本文: 路英进, 曲艳武, 侯亮, 等. 急性冠状动脉综合征患者危险因素的性别差异[J]. 临床心血管病杂志, 2015, 31(8): 835-840. doi: 10.13201/j.issn.1001-1439.2015.08.010
LU Yingjin, QU Yanwu, HOU Liang, et al. Sex differences in risk factors in patients with acute coronary syndrome[J]. J Clin Cardiol, 2015, 31(8): 835-840. doi: 10.13201/j.issn.1001-1439.2015.08.010
Citation: LU Yingjin, QU Yanwu, HOU Liang, et al. Sex differences in risk factors in patients with acute coronary syndrome[J]. J Clin Cardiol, 2015, 31(8): 835-840. doi: 10.13201/j.issn.1001-1439.2015.08.010

急性冠状动脉综合征患者危险因素的性别差异

详细信息
    通讯作者: 丁彦春,E-mail:yanchunding@aliyun.com
  • 中图分类号: R541.4

Sex differences in risk factors in patients with acute coronary syndrome

More Information
  • 目的:研究急性冠状动脉综合征(ACS)患者危险因素的性别差异,为不同性别冠心病患者的临床防治工作提供理论依据。方法:选取2012-03-2014-01在大连医科大学附属二医院心内科住院治疗,符合ACS诊断标准并经过冠脉造影及冠脉支架植入术的1 269例患者,收集患者基本资料、相关病史及血管造影结果,按性别、年龄血脂水平分组,对其冠心病危险因素、血脂水平、冠状动脉病变特点进行统计学分析。结果:女性ACS患者的平均年龄为(68.0±8.5)岁,男性(62.3±11.2)岁,女性的发病年龄晚于男性(P<0.05);ACS伴高血压和糖尿病的女性患者多于男性患者,而有吸烟史的男性明显多于女性(P<0.05);女性患者总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、Apo-a、Apo-b、非高密度脂蛋白胆固醇(non-HDL-C)的平均值均高于男性患者(P<0.05),LDL-C/HDL-C比值与之相反(P<0.05);女性ACS患者HDL-C水平正常的比例均高于同龄组男性,男性HDL-C降低的比例显著高于女性(P<0.05),而HDL-C水平与冠脉病变严重程度的无明显相关性(P>0.05);年龄>55岁患者中non-HDL-C<3.37 mmol/L组和non-HDL-C ≥ 3.37 mmol/L组有显著性别差异(P<0.05),而年龄≤ 55岁患者无此差异(P>0.05),non-HDL-C水平与冠脉病变严重程度的相关性亦无明显性别差异(P>0.05)。结论:年龄≤ 55岁的女性ACS发病率低于同龄组男性,当年龄>55岁时,女性ACS的发病率显著升高;高血压病和糖尿病对女性ACS患者的影响高于男性,而吸烟史对男性ACS患者的影响则高于女性,家族史和体重指数无明显性别差异;ACS患者血脂紊乱存在性别差异;HDL-C和non-HDL-C水平与冠状动脉病变严重程度的相关性无明显性别差异。
  • 加载中
  • [1]

    MEAGHER E A.Addressing cardiovascular disease in women:focus on dyslipidemia[J]. J Am Board Fam Pract, 2004, 17:424-437.

    [2]

    HURST W. The heart, arteries and veins[M].10th ed. New York:McGraw-Hill, 2002:84-96.

    [3]

    胡大一, 杨进刚. 关注女性心脏病的诊疗[J].临床荟萃, 2006, 21(23):1673-1674.

    [4]

    MOSCA L, APPEL L J, BENJAMIN E J, et al. Evidence-based guidelines for cardiovascular disease in women[J]. Circulation, 2004, 109:672-693.

    [5]

    中国成人血脂异常防治指南制定联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志, 2007, 35(5):390-413.

    [6]

    AUSTEN W G, EDWARDS J E, FRYE R L, et al. A reporting system on patients evaluated for coronary artery disease Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association[J]. Circulation, 1975, 51:5-40.

    [7]

    GENSINI G G.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol, 1983, 51:606-607.

    [8]

    AMORETTI F, MARCHES N. Women and coronary disease[J]. Heart, 2008, 94:108-116.

    [9]

    WRITING GROUP MEMBERS, LLOYD-JONES D, ADAMS R J, BROWN T M, et al. Heart Disease and Stroke Statistics-2010 Update:A Report from the American Heart Association[J].Circulation, 2010, 121:e46-e215.

    [10]

    ALLISON M A, MANSON J E, LANGER R D, et al. Association between different measures of blood pressure and coronary artery calcium in postmenopausal Women[J]. Hypertension, 2008, 52:833-840.

    [11]

    DOTE ALL A, HASIDIM D, WALLINGTON L, et al. Diabetes mellitus:clinical presentation and outcome in men and women with acute coronary syndromes[J]. Diabet Med, 2005, 22:1542-1550.

    [12]

    HUXLEY R. BRAZIL R, WOODWARD M. Excess risk of fatal coronary heart disease associated with diabetes in men and women:meta-analysis of 37 prospective cohort studies[J]. BMJ, 2006, 332:73-78.

    [13]

    COLE J H, SPARING L S. Premature coronary artery disease:clinical risk factors and prognosis[J]. Curr Atheroscler Rep, 2004, 6:121-125.

    [14]

    PACKARD C J, FORD I, ROBERTSON M, et al.Plasma lipoproteins and apolipoproteins as predictors of car diovascular risk and treatment benefit in the PRO spective Study of Pravastatin in the Elderly at Risk (PROSPER)[J].Circulation, 2005, 112:3058-3065.

    [15]

    CUI Y, BLUMENTHAL R S, FLAWS J A, et al. Non-high density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality[J].Arch Intern Med, 2001, 161:1413-1419.

  • 加载中
计量
  • 文章访问数:  24
  • PDF下载数:  28
  • 施引文献:  0
出版历程
收稿日期:  2014-12-08
修回日期:  2015-03-11

目录